CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Polyethylene glycol 3350 Na bicarbonate NaCl KCl (Movicol)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00403819
NCT00403819Phase 3Completed
CompareCT.gov

A Phase III Multi-Centre Placebo-Controlled Crossover Study Followed by an Open Label Post-Study Follow-up to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children

Norgine·interventional·Posted Nov 27, 2006·Updated Nov 28, 2006

In Brief

A Phase 3 clinical trial evaluating Polyethylene glycol 3350 Na bicarbonate NaCl KCl (Movicol) for Chronic Constipation. Completed, across 6 sites.

Detailed Summary

A phase III, multi-centre, double blind, placebo controlled, crossover study, followed by an open label post study follow-up, to assess the efficacy and safety of Movicol in the treatment of chronic constipation in children

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Constipation
CountriesUnited Kingdom
Collaborators--

Timeline

Phase 3CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 27, 2006
Enrollment StartApr 1, 2002
Study CompletionApr 1, 2003
TodayJul 2, 2026
Posted 19.6 years ago

Interventions

Polyethylene glycol 3350 Na bicarbonate NaCl KCl (Movicol)drug